A Study of RC48-ADC in Subjects With HER2-negative Locally Advanced or Metastatic Urothelial Cancer

Clinical trial NCT04073602 · COMPLETED

Trial details

NCT number: NCT04073602
Sponsor: RemeGen Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Urothelial Carcinoma

Start date: 2019-08-19
Primary completion: 2022-09-30
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.